Disc Medicine Shares Fall After Wider-Than-Expected Q2 Loss
MT Newswires Live
Aug 07
Disc Medicine (IRON) shares were down 2.4% in recent Thursday trading after the company posted a wider-than-expected loss in Q2.
The company earlier reported a Q2 loss of $1.58 per diluted share, wider than a loss of $1.03 a year earlier.
Analysts polled by FactSet expected a loss of $1.13.
As expected, no revenue was reported for the quarter ended June 30.
The company said that as of June 30, it had cash, cash equivalents, and marketable securities of $650 million, which are expected to fund its operational plans through 2028.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.